CCWM
GILD icon

Cassaday & Co Wealth Management’s Gilead Sciences GILD Stock Holding History

Cassaday & Co Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$123K Buy
972
+172
+22% +$22.7K ﹤0.01% 433
2026
Q1 		$111K Buy
+800
New +$112K ﹤0.01% 434

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Cassaday & Co Wealth Management's GILD Position: Q2 2026 in Review

Cassaday & Co Wealth Management increased its Gilead Sciences (GILD) stake by 22% in Q2 2026, buying an estimated $22.7K and bringing the position to 972 shares worth $123K. The position accounts for ﹤0.01% of the portfolio, ranked #433.

Cassaday & Co Wealth Management first reported a position in GILD in Q1 2026 and has held it in 2 quarters since. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Cassaday & Co Wealth Management held 972 shares of Gilead Sciences worth $123K as of Q2 2026.
  • Cassaday & Co Wealth Management bought 172 Gilead Sciences shares in Q2 2026, an estimated $22.7K.
  • Gilead Sciences made up ﹤0.01% of Cassaday & Co Wealth Management's portfolio in Q2 2026, its #433 holding.
  • Cassaday & Co Wealth Management first reported a position in Gilead Sciences in Q1 2026 and has held it in 2 quarters since.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Cassaday & Co Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.